Invitae Corporation (NVTA) Fundamentals

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.
SHARE INFORMATION
Market Cap$ 1,046,934,043
Shares Outstanding235,266,077
Float207,578,174
Percent Float88.23%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 460,449,000
Latest Fiscal EPS$ -1.89
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions658
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months19,624,924
Institutional Holdings Percent143.3%
Institutional Sold Previous 3 Months38,923,329
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,362,905
Insider Holdings Percent1.7
Insider Sold Previous 3 Months85,931
Insider Shares Owned3,887,820
TRADING INFO
52 Week High$ 32.93
52 Week Low$ 1.83
52 Week High Change$ -82.58
21 Day Moving Average$ 2.9652
21 Day Extended Moving Average$ 3.4994
50 Day Moving Average$ 2.799
50 Day Extended Moving Average$ 3.3749
200 Day Moving Average$ 9.1469
200 Day Extended Moving Average$ 9.7025
10 Day Average Volume64,562,765
20 Day Average Volume37,123,136
30 Day Average Volume27,588,570
50 Day Average Volume20,978,332
Alpha-0.017546
Beta1.8048
Standard Deviation0.240332
R20.141081
7 Day Price Change$ 2.16
7 Day Percent Change94.32%
21 Day Price Change$ 2.51
21 Day Percent Change129.38%
30 Day Price Change$ 1.60
30 Day Percent Change56.14%
Month to Date Price Change$ 2.55
Month to Date Percent Change134.21%
Quarter to Date Price Change$ 2.01
Quarter to Date Percent Change82.38%
180 Day Price Change$ -6.24
180 Day Percent Change-58.37%
200 Day Price Change$ -5.77
200 Day Percent Change-56.46%
Year to Date Price Change$ -10.82
Year to Date Percent Change-70.86%

Invitae Corporation (NVTA) Key Ratios

PROFITABILITY
EBIT Margin-619.9%
EBITDA Margin-598.0%
Pre-Tax Profit Margin-163.5%
Profit Margin Count-93.93%
Gross Margin19.5%
Profit Margin TOT-93.93%
INCOME STATEMENTS
Revenue$ 500,829,000
Revenue Per Share$ 2.1288
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.60
Total Debt To Equity4.50
Int Coverage-55.30
Current Ratio6.40
Leverage Ratio1.80
Quick Ratio5.80
Long Term Debt To Capital0.82
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ 2,204,756,045
Price to Sales2.0904
Price to Free Cash-1.50
PE High Last 5 Years-3.90
Price To Book3.10
Price To Cash Flow0.00
PE Low Last 5 Years-5.20
Price to Tangible Book-1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.80
Invoice Turnover10.40
Assets Turnover0.20
Return Assets-92.73
Return on Equity-227.64
Return on Capital-93.91

Invitae Corporation (NVTA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOKenneth D. Knight
Emplyoees2900
Last AuditUQ
CIK0001501134
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSMedical Laboratories(621511)
CONTACT INFO
Address1400 16th Street
San Francisco, CA 94103
Websitehttps://www.invitae.com
Facsimile-
Telephone+1 415 374-7782
Emailir@invitae.com


Your Recent History
NYSE
NVTA
Invitae
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.